Management of Peyronie's Disease With Adipose Tissue Stem Cell
The Role of Adipose Tissue Stem Cell Injection Through Corpora Cavernosa and Intra Dorsal Penile Artery in Management of Erectile Dysfunction Associated With Peyronie's Disease
1 other identifier
interventional
20
1 country
2
Brief Summary
Erectile dysfunction is growing in prevalence all over the world and one of the most existing disease in old age patients There is many lines of treatment concerning the status of patient like psychosexual, medical, and surgical treatment But Pyronie's disease is common now among people especially diabetics, and the role of treatment still controversial in results We can start conservative treatment and then surgical treatment if fail but the outcome still not convinced Many patients refuse to fix penile prosthesis and to make operation like nesbite for probability of shortening of penis We start to use stem cell in patients have erectile dysfunction and Peyronie's disease The injection of stem cell will be at corpora cavernosa and intra dorsal penile artery under Doppler device guidance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2013
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 6, 2014
CompletedFirst Posted
Study publicly available on registry
April 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedApril 10, 2015
April 1, 2015
2.9 years
January 6, 2014
April 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sexual function questionnaire
Clinical history of patients before and after treatment Penile duplex study
2-3 months
Secondary Outcomes (1)
Penile plaque assessment
2-3 months
Study Arms (1)
Adipose tissue stem cell injection
EXPERIMENTALThe stem cell will be harvested by liposuction and injection will be at corpora cavernosa and dorsal penile artery
Interventions
Stem cell will be harvested through adipose tissue by liposuction and isolation occurred Injection will distribute through corpora cavernosa and dorsal penile artery
Eligibility Criteria
You may qualify if:
- erectile dysfunction associated with Peyroni's diseas
You may not qualify if:
- nil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Man clinic for andrology and male infertility
Cairo, Cairo Governorate, 33611, Egypt
Man clinic
Cairo, 11366, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Khaled A Gadalla, MD, ABS
Man clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
January 6, 2014
First Posted
April 10, 2015
Study Start
June 1, 2013
Primary Completion
May 1, 2016
Study Completion
July 1, 2016
Last Updated
April 10, 2015
Record last verified: 2015-04